Financing ·
Glucotrack issues warrants for 406,198 shares to waive restrictions on future equity issuances
GCTKGlucotrack, Inc.
On October 13, 2026, Glucotrack entered into a Waiver Agreement with holders of existing warrants. The agreement waives restrictions on the company's ability to issue new common stock or equivalents for 90 days and removes exercise price adjustments under certain variable rate transactions. In exchange, Glucotrack issued new warrants exercisable at $7.50 per share for an aggregate of 406,198 shares. These new warrants expire in five years and require future stockholder approval to be exercisable. The company operates in the healthcare technology sector, developing digital health solutions.